NRG1 is up-regulated in several types of cancer including breast cancer, lung cancer, pancreatic cancer, and over-expression of NRG1 may activate downstream signaling pathways such as ERBB3/ERBB2 pathway, leading to the stimulation on cancer cell proliferation, invasion, and drug resistance 13. This evidence concerns the gene ERBB3 and lung cancer.